logo
Curaleaf to Report Second Quarter 2025 Financial and Operational Results

Curaleaf to Report Second Quarter 2025 Financial and Operational Results

Yahoo08-07-2025
STAMFORD, Conn., July 8, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second quarter ended June 30, 2025 after market close on August 6, 2025.
Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights.
Event:Curaleaf Second Quarter 2025 Financial Earnings Conference Call
Date:Wednesday, August 6, 2025
Time:5:00 p.m. ET
Live Call:+1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International)
Passcode:3090114
Webcast:https://ir.curaleaf.com/eventsFor interested individuals unable to join the conference call, a dial-in replay of the call will be available until August 13, 2025, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 1472267
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR
Investor Relations Website: https://ir.curaleaf.com/
Investor Contact: Curaleaf Holdings, Inc.Camilo Lyon, Chief Investment Officer IR@curaleaf.com
Media Contact: Curaleaf Holdings, Inc.Jordon Rahmil, VP Corporate Communicationsmedia@curaleaf.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-to-report-second-quarter-2025-financial-and-operational-results-302500156.html
SOURCE Curaleaf Holdings, Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2025/08/c3040.html
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor
Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

Yahoo

time10 minutes ago

  • Yahoo

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

DALLAS, July 29, 2025--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy to an Individual Investor. The acquisition closed June 27, 2025. Based in Rockwall, Texas, The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy offers comprehensive physical, occupational, and speech therapy for children from birth up to seventeen years old. Founded and operated by experienced physical therapists with over 40 years of combined expertise, the clinic treats a range of neurological, orthopedic, and developmental conditions—such as sensory processing disorders, autism, ADHD, cerebral palsy, and feeding issues—using both innovative and traditional tools. With a highly trained staff and a state-of-the-art facility, Excel Pediatric Therapy is committed to intensive treatment, caregiver education, and creating enjoyable therapy environments that promote sustainable progress. Whether families are seeking early intervention or long-term support, Excel Pediatric Therapy works to "make a difference…one child at a time." Generational Group Executive Managing Director, M&A, Central Region – Michael Goss, and his team led by Vice President, M&A, Jacob Mangalath successfully closed the deal. Senior Managing Director, Doug Morrow and Senior M&A Advisor, Mike Moore, established the initial relationship with The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy. Ryan Binkley, CEO of Generational Group, stated, "We're committed to delivering results that generate long-term value for all stakeholders. This milestone reflects the effectiveness of our strategy and the trust our clients consistently place in us." About Generational Group Generational Group, headquartered in Dallas, TX, is a leading, award winning full-service M&A advisory firm. Generational has over 300 professionals across 16 offices in North America. The firm empowers business owners to unlock the full value of their companies through a comprehensive suite of services—including strategic growth consulting, exit planning education, business valuation, value enhancement strategies, M&A advisory, digital solutions, and wealth management. Celebrating its 20th year, Generational has successfully closed over 1,700 transactions and has ranked #1 or #2 in all LSEG league tables for deals valued between $25 million and $1 billion in 2022, 2023, and 2024. The firm was named 2024 USA Investment Banking Firm of the Year by the Global M&A Network and recognized as Investment Banking Firm of the Year by The M&A Advisor in both 2024 and 2022. View source version on Contacts Media Contact:Catherine Binkley469-828-2798cbinkley@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It
Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It

Yahoo

time40 minutes ago

  • Yahoo

Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It

Inc. (NASDAQ:AMZN) is one of the . On July 28, UBS analyst Stephen Ju raised the price target on the stock to $271.00 (from $249.00) while maintaining a Buy rating. The price target increase reflects UBS's decision to roll back some of the decreases in estimates it had made three months ago when it was expecting increased demand destruction from tariffs. The firm has raised its Gross Merchandise Value (GMV) estimates for 2026 by an estimated 2%, along with a 2% increase in gross profit projections. Moreover, it has also raised its 2026 and 2027 advertising segment forecasts by an estimated 3% due to better-than-expected advertising performance. Meanwhile, AWS growth estimates were maintained at 16% for the second quarter of 2025. 25 best things to buy on Amazon under $20 (Photo credit: Pixabay) Based on the revisions, there is a 1% increase in 2026 revenue estimates and a 5% increase in EBIT (Earnings Before Interest and Taxes) projections. For the year 2027, the firm projects a 0.1% revenue increase and a 7% EBIT increase. The firm also raised its 2025 CapEx forecast to $112 billion from the previous $107 billion after the company disclosed its first-quarter 2025 capital expenditures. Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor
Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

Business Wire

time41 minutes ago

  • Business Wire

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

DALLAS--(BUSINESS WIRE)-- Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy to an Individual Investor. The acquisition closed June 27, 2025. Based in Rockwall, Texas, The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy offers comprehensive physical, occupational, and speech therapy for children from birth up to seventeen years old. Founded and operated by experienced physical therapists with over 40 years of combined expertise, the clinic treats a range of neurological, orthopedic, and developmental conditions—such as sensory processing disorders, autism, ADHD, cerebral palsy, and feeding issues—using both innovative and traditional tools. With a highly trained staff and a state-of-the-art facility, Excel Pediatric Therapy is committed to intensive treatment, caregiver education, and creating enjoyable therapy environments that promote sustainable progress. Whether families are seeking early intervention or long-term support, Excel Pediatric Therapy works to 'make a difference…one child at a time.' Generational Group Executive Managing Director, M&A, Central Region – Michael Goss, and his team led by Vice President, M&A, Jacob Mangalath successfully closed the deal. Senior Managing Director, Doug Morrow and Senior M&A Advisor, Mike Moore, established the initial relationship with The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy. Ryan Binkley, CEO of Generational Group, stated, 'We're committed to delivering results that generate long-term value for all stakeholders. This milestone reflects the effectiveness of our strategy and the trust our clients consistently place in us.' About Generational Group Generational Group, headquartered in Dallas, TX, is a leading, award winning full-service M&A advisory firm. Generational has over 300 professionals across 16 offices in North America. The firm empowers business owners to unlock the full value of their companies through a comprehensive suite of services—including strategic growth consulting, exit planning education, business valuation, value enhancement strategies, M&A advisory, digital solutions, and wealth management. Celebrating its 20 th year, Generational has successfully closed over 1,700 transactions and has ranked #1 or #2 in all LSEG league tables for deals valued between $25 million and $1 billion in 2022, 2023, and 2024. The firm was named 2024 USA Investment Banking Firm of the Year by the Global M&A Network and recognized as Investment Banking Firm of the Year by The M&A Advisor in both 2024 and 2022.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store